Compare CODA & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CODA | SEER |
|---|---|---|
| Founded | 1994 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.7M | 108.0M |
| IPO Year | 2007 | 2020 |
| Metric | CODA | SEER |
|---|---|---|
| Price | $10.11 | $2.20 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $14.00 | N/A |
| AVG Volume (30 Days) | 104.3K | ★ 307.1K |
| Earning Date | 09-14-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 15.62 | 9.40 |
| EPS | ★ 0.36 | N/A |
| Revenue | ★ $20,316,161.00 | $16,578,000.00 |
| Revenue This Year | $9.92 | N/A |
| Revenue Next Year | $17.26 | $20.50 |
| P/E Ratio | $28.51 | ★ N/A |
| Revenue Growth | 4.98 | ★ 16.99 |
| 52 Week Low | $7.80 | $1.55 |
| 52 Week High | $18.00 | $2.41 |
| Indicator | CODA | SEER |
|---|---|---|
| Relative Strength Index (RSI) | 37.62 | 59.89 |
| Support Level | $9.82 | $1.75 |
| Resistance Level | $10.66 | $2.30 |
| Average True Range (ATR) | 0.35 | 0.11 |
| MACD | -0.11 | 0.02 |
| Stochastic Oscillator | 0.13 | 69.75 |
Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company operates in three distinct business segments: the Marine Technology business, Acoustic Sensors and Material Business and the Defense Engineering Services Business. Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.